$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

$nvos Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223019347 Filed on May 26, 2023

Income Statement

Concept	2023 Q1	2022 Q3	2022 Q1
Revenue	$2.557M	$11.74M	$2.869M
YoY Change	-10.9%	335.89%	37.94%
Cost Of Revenue	$1.586M	$6.939M	$1.653M
YoY Change	-4.07%	305.0%	25.22%
Gross Profit	$970.9K	$4.799M	$1.216M
YoY Change	-20.18%	389.9%	62.18%
Gross Profit Margin	37.98%	40.89%	42.39%
Selling, General & Admin	$2.758M	$14.39M	$3.337M
YoY Change	-17.36%	419.67%	60.43%
% of Gross Profit	284.04%	299.74%	274.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$552.6K	$669.8K	$773.6K
YoY Change	-28.56%	10.68%	103.57%
% of Gross Profit	56.92%	13.96%	63.6%
Operating Expenses	$2.758M	$14.39M	$3.337M
YoY Change	-17.36%	419.67%	60.43%
Operating Profit	-$1.787M	-$9.586M	-$2.121M
YoY Change	-15.74%	435.98%	59.45%
Interest Expense	$123.9K	-$8.041M	-$2.748M
YoY Change	-104.51%	10481.41%	27375.2%
% of Operating Profit
Other Income/Expense, Net	-$2.858M	$0.00	-$2.748M
YoY Change	4.03%
Pretax Income	-$4.645M	-$33.07M	-$4.868M
YoY Change	-4.58%	1602.78%	263.3%
Income Tax		-$22.30K
% Of Pretax Income
Net Earnings	-$4.621M	-$32.85M	-$4.868M
YoY Change	-5.07%	1593.59%	263.14%
Net Earnings / Revenue	-180.77%	-279.86%	-169.67%
Basic Earnings Per Share	-$0.06		-$0.17
Diluted Earnings Per Share	-$0.06	-$1.13	-$167.2K
COMMON SHARES
Basic Shares Outstanding	144.3M shares	31.02M shares	28.74M shares
Diluted Shares Outstanding	7.933M shares

Balance Sheet

Concept	2023 Q1	2022 Q3	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$609.7K	$2.179M	$15.94M
YoY Change	-96.18%	-73.73%	837.88%
Cash & Equivalents	$609.7K	$2.179M	$15.94M
Short-Term Investments
Other Short-Term Assets	$546.6K	$571.3K	$503.4K
YoY Change	8.57%	161.63%	19.87%
Inventory	$925.1K	$879.0K	$334.4K
Prepaid Expenses
Receivables	$923.6K	$1.017M	$1.252M
Other Receivables	$1.046M	$1.085M	$981.6K
Total Short-Term Assets	$4.051M	$5.732M	$19.02M
YoY Change	-78.7%	-48.52%	428.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.449M	$5.801M	$8.506M
YoY Change	-35.94%	-4.44%	195.35%
Goodwill	$7.539M	$7.826M
YoY Change		-17.53%
Intangibles	$17.20M	$18.84M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$32.44M	$35.14M	$51.30M
YoY Change	-36.77%	-30.86%	64.12%
TOTAL ASSETS
Total Short-Term Assets	$4.051M	$5.732M	$19.02M
Total Long-Term Assets	$32.44M	$35.14M	$51.30M
Total Assets	$36.49M	$40.87M	$70.32M
YoY Change	-48.11%	-34.03%	101.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.040M	$1.800M	$1.106M
YoY Change	84.5%	24.17%	22.86%
Accrued Expenses	$1.223M	$1.116M	$2.336M
YoY Change	-47.66%	-1.17%	88.42%
Deferred Revenue	$35.44K	$36.89K
YoY Change		-4.51%
Short-Term Debt	$890.2K	$9.579M	$2.046M
YoY Change	-56.48%	1900.03%	278.86%
Long-Term Debt Due	$1.020M	$8.890K	$5.278M
YoY Change	-80.68%	-99.8%	444.08%
Total Short-Term Liabilities	$6.178M	$14.07M	$11.55M
YoY Change	-46.53%	66.29%	215.68%
LONG-TERM LIABILITIES
Long-Term Debt	$64.98K	$1.120M	$10.89M
YoY Change	-99.4%	-81.74%
Other Long-Term Liabilities	$1.891M	$2.185M	$1.867M
YoY Change	1.27%	6.2%	-9.38%
Total Long-Term Liabilities	$1.956M	$3.305M	$12.75M
YoY Change	-84.67%	-59.64%	519.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.178M	$14.07M	$11.55M
Total Long-Term Liabilities	$1.956M	$3.305M	$12.75M
Total Liabilities	$9.526M	$18.83M	$25.77M
YoY Change	-63.03%	3.7%	354.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$62.38M	-$53.82M
YoY Change		156.65%
Common Stock	$139.6K	$31.18K
YoY Change		17.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.25M	$22.31M	$44.55M
YoY Change
Total Liabilities & Shareholders Equity	$36.49M	$40.87M	$70.32M
YoY Change	-48.11%	-34.03%	101.72%

Cashflow Statement

Concept	2023 Q1	2022 Q3	2022 Q1
OPERATING ACTIVITIES
Net Income	-$4.621M	-$32.85M	-$4.868M
YoY Change	-5.07%	1593.59%	263.14%
Depreciation, Depletion And Amortization	$552.6K	$669.8K	$773.6K
YoY Change	-28.56%	10.68%	103.57%
Cash From Operating Activities	-$878.6K	$675.8K	-$2.251M
YoY Change	-60.96%	-190.64%	703.8%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$800.00	-$72.14K
YoY Change	-100.0%	-98.53%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$0.00	$810.00	-$72.14K
YoY Change	-100.0%	-99.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	429.3K	-11.23M	9.440M
YoY Change	-95.45%	294.69%	-47299.65%
NET CHANGE
Cash From Operating Activities	-878.6K	675.8K	-2.251M
Cash From Investing Activities	0.000	810.0	-72.14K
Cash From Financing Activities	429.3K	-11.23M	9.440M
Net Change In Cash	-449.3K	-10.55M	7.117M
YoY Change	-106.31%	-11849.09%	-2472.39%
FREE CASH FLOW
Cash From Operating Activities	-$878.6K	$675.8K	-$2.251M
Capital Expenditures	$0.00	-$800.00	-$72.14K
Free Cash Flow	-$878.6K	$676.6K	-$2.178M
YoY Change	-59.67%	-197.92%	678.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001138978
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2021Q4	NVOS	Stock Issued During Period Value Common Stock Issued To Be Held In Escrow StockIssuedDuringPeriodValueCommonStockIssuedToBeHeldInEscrow		usd
	NVOS	Common Stock Issued For Services CommonStockIssuedForServices		usd
	NVOS	Financing Costs For Debt Extension FinancingCostsForDebtExtension		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	NVOS	Common Stock Issued For Convertible Debt CommonStockIssuedForConvertibleDebt		usd
	NVOS	Common Stock Issued For Intangible Assets CommonStockIssuedForIntangibleAssets		usd
	NVOS	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition		usd
	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability		usd
	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote		usd
	NVOS	Extinguishment Of Derivative Liability Due To Conversions ExtinguishmentOfDerivativeLiabilityDueToConversions		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	NVOS	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes		usd
	NVOS	Other Receivable Write Offs OtherReceivableWriteOffs		usd
CY2023Q1	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2022Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2022Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent		usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023Q1	NVOS	Capital Expenditures CapitalExpenditures		usd
	NVOS	Capital Expenditures CapitalExpenditures		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-02-28
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40089
	dei	Entity Registrant Name EntityRegistrantName	Novo Integrated Sciences, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-3691650
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11120 NE 2nd Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bellevue
	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98004
	dei	City Area Code CityAreaCode	(206)
	dei	Local Phone Number LocalPhoneNumber	617-9797
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	NVOS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	144857518	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	609738	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2178687	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	923556	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1017405	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	925107	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	879033	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1045619	usd
CY2022Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1085335	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	546604	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	571335	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	4050624	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	5731795	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5449163	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5800648	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17199620	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18840619	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2250442	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2673934	usd
CY2023Q1	us-gaap	Goodwill Goodwill	7539469	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd
CY2023Q1	us-gaap	Assets Assets	36489318	usd
CY2022Q3	us-gaap	Assets Assets	40872840	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2040073	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1800268	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1222832	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1116125	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	469308	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	454189	usd
CY2023Q1	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent	92050	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	307623	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	307623	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	421489	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	9099654	usd
CY2023Q1	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	62388	usd
CY2022Q3	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	534595	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	468749	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	478897	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	15938	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8890	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	473628	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	582088	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6178078	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14074706	usd
CY2022Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	946250	usd
CY2023Q1	NVOS	Notes And Loan Payable Non Current NotesAndLoanPayableNonCurrent	64977	usd
CY2022Q3	NVOS	Notes And Loan Payable Non Current NotesAndLoanPayableNonCurrent	161460	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	12076	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1890624	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2185329	usd
CY2023Q1	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1392553	usd
CY2022Q3	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1445448	usd
CY2023Q1	us-gaap	Liabilities Liabilities	9526232	usd
CY2022Q3	us-gaap	Liabilities Liabilities	18825269	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139626576	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139626576	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31180603	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31180603	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	139626	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	31181	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	88320971	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66056824	usd
CY2023Q1	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	911392	shares
CY2022Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	4149633	shares
CY2023Q1	NVOS	Common Stock Subscribed But Unissued Subscriptions Receivable CommonStockSubscribedButUnissuedSubscriptionsReceivable	1217293	usd
CY2022Q3	NVOS	Common Stock Subscribed But Unissued Subscriptions Receivable CommonStockSubscribedButUnissuedSubscriptionsReceivable	9474807	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-51993	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	560836	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62375257	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53818489	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	27250640	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	22305159	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-287554	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	-257588	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26963086	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22047571	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36489318	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40872840	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2556509	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2869223	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5975789	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6031150	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1585606	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	1652869	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3265353	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3548330	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	970903	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1216354	usd
	us-gaap	Gross Profit GrossProfit	2710436	usd
	us-gaap	Gross Profit GrossProfit	2482820	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	707	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	26370	usd
	us-gaap	Selling Expense SellingExpense	8039	usd
	us-gaap	Selling Expense SellingExpense	26538	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2757006	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3310660	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6731167	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5940617	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2757713	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	3337030	usd
	us-gaap	Operating Expenses OperatingExpenses	6739206	usd
	us-gaap	Operating Expenses OperatingExpenses	5967155	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1786810	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2120676	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4028770	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3484335	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2243	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	8490	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4524	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	16878	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	123866	usd
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1226182	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	291109	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1294912	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2740349	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1463022	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4230862	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1520862	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3620	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-66814	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-35681	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-401368	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2858352	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2747528	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4553128	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3200264	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4645162	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4868204	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8581898	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6684599	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-4868204	usd
	us-gaap	Profit Loss ProfitLoss	-8581898	usd
	us-gaap	Profit Loss ProfitLoss	-6684599	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-23807	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-63037	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-25130	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-72845	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4621355	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4805167	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8556768	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6611754	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-4868204	usd
	us-gaap	Profit Loss ProfitLoss	-8581898	usd
	us-gaap	Profit Loss ProfitLoss	-6684599	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-196683	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	115093	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-617665	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10705	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4841845	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4753111	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9199563	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6673894	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79334919	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28740700	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56469365	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27827686	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22047571	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1795000	usd
CY2022Q4	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	1139050	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-420982	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-3936736	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20684790	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9086051	usd
CY2023Q1	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	282533	usd
CY2023Q1	NVOS	Stock Issued During Period Value Exercise Value Of Warrants For Cash StockIssuedDuringPeriodValueExerciseValueOfWarrantsForCash	131000	usd
CY2023Q1	NVOS	Stock Issued During Period Value Share Value Issued With Convertible Notes StockIssuedDuringPeriodValueShareValueIssuedWithConvertibleNotes	82963	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	86327	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	1390380	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-196683	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26963086	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43804155	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	64750	usd
CY2021Q4	NVOS	Stock Issued During Period Value Purchase Of Asset StockIssuedDuringPeriodValuePurchaseOfAsset	1081236	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	188925	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	295824	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	154135	usd
CY2021Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-104388	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-1816395	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43668242	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43668242	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	298000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5257466	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	44427	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	115093	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-4868204	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44515024	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44515024	usd
	us-gaap	Profit Loss ProfitLoss	-8581898	usd
	us-gaap	Profit Loss ProfitLoss	-6684599	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1138797	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1467837	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-121774	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-198562	usd
	NVOS	Common Stock Issued For Services CommonStockIssuedForServices	362750	usd
	NVOS	Financing Costs For Debt Extension FinancingCostsForDebtExtension	-1421583	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	419256	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	289626	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4230862	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1520862	usd
	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	35681	usd
	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	401368	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-57936	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-213125	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	78898	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-46135	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6143	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	285444	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	299881	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-422847	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	148918	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-111479	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	4000000	shares
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	28226	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	277075	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-405082	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-282703	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1156821	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3009732	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	192536	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	29291	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-163245	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	6138	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-4350	usd
	NVOS	Repayments Of Finance Leases RepaymentsOfFinanceLeases	4299	usd
	NVOS	Repayments Of Finance Leases RepaymentsOfFinanceLeases	10934	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4415000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1795000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	131000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2977778	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	445235	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	15270000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-604704	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10839716	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	192576	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-15904	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1568949	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7650835	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2178687	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8293162	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	609738	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15943997	usd
	us-gaap	Interest Paid Net InterestPaidNet	275990	usd
	us-gaap	Interest Paid Net InterestPaidNet	1294912	usd
	NVOS	Common Stock Issued For Convertible Debt CommonStockIssuedForConvertibleDebt	9086051	usd
	NVOS	Common Stock Issued For Intangible Assets CommonStockIssuedForIntangibleAssets	188925	usd
	NVOS	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition	983925	usd
	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability	1390380	usd
	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote	297055	usd
	NVOS	Extinguishment Of Derivative Liability Due To Conversions ExtinguishmentOfDerivativeLiabilityDueToConversions	1390380	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	82963	usd
	NVOS	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	86327	usd
CY2021Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	the Company effected a 1-for-10 reverse stock split of our common stock. As a result of the reverse stock split, every 10 shares of issued and outstanding common stock were exchanged for one share of common stock, with any fractional shares being rounded up to the next higher whole share. Unless otherwise noted, the share and per share information in this report have been retroactively adjusted to give effect to the 1-for-10 reverse stock split
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	992329	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_z00hubhkAO51" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zsXDeqXYz6M8">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to going concern assessment, useful lives of non-current assets, impairment of non-current assets, allowance for doubtful receivables, allowance for slow moving and obsolete inventory, valuation of share-based compensation and warrants, and valuation allowance for deferred tax assets. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	936759	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	990064	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1027670	usd
CY2022	NVOS	Other Receivable Write Offs OtherReceivableWriteOffs	299672	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	225924	usd
CY2022Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	73748	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6556945	usd
	NVOS	Schedule Of Intangible Assets Amortized Estimated Useful Lives ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives	<p id="xdx_89B_ecustom--ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives_zepGb7XjenQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s intangible assets are being amortized over their estimated useful lives as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zhPdVmGyo0tj" style="display: none">Schedule of Intangible Assets Amortized Estimated Useful Lives</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land use rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_pp0p0_dtY_c20230228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LandUseRightsMember_zmhfQIM5Oq3l" title="Intangible assets, estimated lives">50</span> years (the lease period)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_pp0p0_dtY_c20230228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zpBzeV9yR8gi" title="Intangible assets, estimated lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_pp0p0_dtY_c20230228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zCikOMnE4GY8" title="Intangible assets, estimated lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand names</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_pp0p0_dtY_c20230228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zL3gnAMw9Tnj" title="Intangible assets, estimated lives">7</span> years</span></td></tr> </table>
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1357043	usd
CY2021Q3	us-gaap	Goodwill Goodwill	9488848	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	602	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1357043	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-306563	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-286375	usd
CY2023Q1	us-gaap	Goodwill Goodwill	7539469	usd
CY2023Q1	us-gaap	Goodwill Goodwill	7539469	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-617665	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-431605	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1027670	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	925107	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ztH15Z9SlaFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_862_zfgt7rD5w0jd">Reclassifications</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts were reclassified to conform to the manner of presentation in the current period. These reclassifications had no effect on the net loss or shareholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Inventory Net InventoryNet	879033	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	1045619	usd
CY2022Q3	us-gaap	Other Receivables OtherReceivables	1085335	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1045619	usd
CY2022Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1085335	usd
CY2023Q1	NVOS	Trade Receivables TradeReceivables	1807663	usd
CY2022Q3	NVOS	Trade Receivables TradeReceivables	1829475	usd
CY2023Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	52652	usd
CY2022Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	180259	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1860315	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2009734	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	936759	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	992329	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	923556	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1017405	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	695520	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1259954	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	134234	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	139333	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1085417	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	507416	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	1915171	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	1906703	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	990064	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6805380	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1107782	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1004732	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5449163	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5800648	usd
	us-gaap	Depreciation Depreciation	134123	usd
	us-gaap	Depreciation Depreciation	156067	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23259387	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23943175	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6059767	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5102556	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17199620	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18840619	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1004674	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1311770	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2001908	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2001908	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1694877	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1420217	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1108057	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	8972653	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17199620	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4768	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	4768	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	4768	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	4768	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	45905	usd
CY2023Q1	NVOS	Accrued Liabilities Gross Current AccruedLiabilitiesGrossCurrent	969707	usd
CY2022Q3	NVOS	Accrued Liabilities Gross Current AccruedLiabilitiesGrossCurrent	884024	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	217683	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	195214	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35442	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	36887	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1222832	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1116125	usd
	NVOS	Government Loans And Note Payable GovernmentLoansAndNotePayable	<p id="xdx_80F_ecustom--GovernmentLoansAndNotePayable_zjix5pJ39iZc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10 – <span id="xdx_822_zL3b9EJFgR7l">Government Loans and Notes Payable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfDebtTableTextBlock_zN8j0Nz52MR4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable at February 28, 2023 and August 31, 2022 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zurebiKHlEEd" style="display: none">Schedule of Governmental Loans and Note Payable</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">February 28,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">August 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Government loans issued under the Government of Canada’s Canada Emergency Business Account (“CEBA”) program (A).</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--NotesAndLoansPayable_iI_pp0p0_c20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_fKEEp_zXid82FuLgrj" style="width: 16%; text-align: right" title="Total government loans and notes payable">88,177</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--NotesAndLoansPayable_iI_pp0p0_c20220831__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_fKEEp_zNGoKURtI7Xb" style="width: 16%; text-align: right" title="Total government loans and notes payable">91,526</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Note payable to the Small Business Administration (“SBA”). The note bears interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20220901__20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zsvbvWb7mmGk" title="Debt Instrument, Interest Rate During Period"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20210901__20220831__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zxPCPHAPlBj7" title="Debt Instrument, Interest Rate During Period">3.75</span></span>% per annum, requires <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20220901__20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zFlvXyjZcrta" title="Frequency of periodic payment"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20210901__20220831__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zPcY46kq7pIb" title="Frequency of periodic payment">monthly</span></span> payments of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20220901__20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zGprnhQMjMt1" title="Periodic payment"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20210901__20220831__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zwnyOMWeBqGi" title="Periodic payment">190</span></span> and is due 30 years from the date of issuance, and is secured by certain equipment of PRO-DIP.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--NotesAndLoansPayable_iI_pp0p0_c20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zXRf1QrGmN3g" style="text-align: right" title="Total government loans and notes payable">40,320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--NotesAndLoansPayable_iI_pp0p0_c20220831__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zbE0mFj9lK28" style="text-align: right" title="Total government loans and notes payable">40,320</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Note payable dated December 3, 2018; accrues interest at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20220901__20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableThreeMember_zsV85oQPS691" title="Debt Instrument, Interest Rate During Period"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20210901__20220831__us-gaap--DebtInstrumentAxis__custom--NotesPayableThreeMember_zVXFannnxT32" title="Debt Instrument, Interest Rate During Period">4.53</span></span>% per annum; unsecured; <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20220901__20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableThreeMember_zYezsWozhhj8" title="Frequency of periodic payment"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20210901__20220831__us-gaap--DebtInstrumentAxis__custom--NotesPayableThreeMember_zmD4uFkrkg6i" title="Frequency of periodic payment">annual</span></span> payments of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20220901__20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableThreeMember_zuhCLWrIeUga" title="Periodic payment"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20210901__20220831__us-gaap--DebtInstrumentAxis__custom--NotesPayableThreeMember_z1h0SNOzdC47" title="Periodic payment">4,000</span></span>; due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_pp0p0_c20220901__20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableThreeMember_zaoRnPviNNTl" title="Debt Instrument, Maturity Date"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_pp0p0_c20220901__20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableThreeMember_zKUaMcWN8E3b" title="Debt Instrument, Maturity Date">December 31, 2028</span></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--NotesAndLoansPayable_iI_pp0p0_c20230228__us-gaap--DebtInstrumentAxis__custom--NotesPayableThreeMember_zrYCuo509JS5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total government loans and notes payable">28,530</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--NotesAndLoansPayable_iI_pp0p0_c20220831__us-gaap--DebtInstrumentAxis__custom--NotesPayableThreeMember_zXDmvvzYvaL5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total government loans and notes payable">29,614</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total government loans and notes payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--NotesAndLoansPayable_iI_pp0p0_c20230228_zIQmKOPPC5A9" style="text-align: right" title="Total government loans and notes payable">157,027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--NotesAndLoansPayable_iI_pp0p0_c20220831_zgYZjYjaU7Mb" style="text-align: right" title="Total government loans and notes payable">161,460</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--NotesAndLoansPayableCurrent_iNI_pp0p0_di_c20230228_zy0hF68Bogu6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less current portion">(92,050</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--NotesAndLoansPayableCurrent_iI_pp0p0_c20220831_zs687DMZgJNi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less current portion"><span style="-sec-ix-hidden: xdx2ixbrl1335">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermNotesAndLoans_iI_pp0p0_c20230228_zrkOk8h05SG" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-term portion">64,977</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--LongTermNotesAndLoans_iI_pp0p0_c20220831_zrorAZky2Ne1" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-term portion">161,460</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F0C_zOcKjI4dUqj1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zjhU5KzPqIf9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Government of Canada launched CEBA loan to ensure that small businesses have access to the capital that they need during the current challenges faced due to the COVID-19 virus. The Company obtained CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--NotesPayable_iI_pp0p0_uCAD_c20230228__us-gaap--DebtInstrumentAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zZHmJIJg4i11" title="Notes Payable">80,000</span> loan (US$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--NotesPayable_iI_pp0p0_uUSD_c20230228__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zSr1YXl64V8h" title="Loan amount">58,785</span>, at February 28, 2023), which is unsecured, non-interest bearing and due on or before <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20220901__20230228_z2aqwczFPcV9" title="Debt instrument, maturity date">December 31, 2023</span>. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--DebtInstrumentDescription_c20220901__20230228_zsh5vIoNiF29" title="Debt description">If the loan amount is paid on or before December 31, 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_ecustom--DebtInstrumentForgivenessApplicableRepaymentRate_dp_uPure_c20220901__20230228_zhr1bYNas2Ql" title="Forgiveness percentage">25</span>% of the loan will be forgiven (“Early Payment Credit”). In the event that the Company does not repay <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_ecustom--DebtInstrumentDefaultRepaymentPercentage_pid_dp_uPure_c20220901__20230228_zHsGLlpadaWh" title="Default in repayment rate">75</span>% of such term debt on or before December 31, 2023, the Early Payment Credit will not apply</span>. In addition, with acquisition of Terragenx, the Company acquired a CEBA loan in the amount of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--NotesPayable_iI_pp0p0_uCAD_c20230228__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--CanadaEmergencyBusinessAccountLoanMember__us-gaap--BusinessAcquisitionAxis__custom--TerragenxMember_zNhwE0UbpPs4" title="Notes Payable">60,000</span> net of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--RepaymentsOfSeniorDebt_pp0p0_uCAD_c20220901__20230228_zrGEvUftQoX2" title="Repayment of debt">20,000</span> repayment (US$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIEdvdmVybm1lbnRhbCBMb2FucyBhbmQgTm90ZSBQYXlhYmxlIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20230228__us-gaap--AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis__custom--CanadaEmergencyBusinessAccountLoanMember__us-gaap--BusinessAcquisitionAxis__custom--TerragenxMember_zMedtYtjCDGi" title="Notes Payable">29,392</span> at February 28, 2023) under the same terms.</span></td></tr> </table> <p id="xdx_8A4_zWbY1uymf4Df" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zQK1JrPtJU8d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future scheduled maturities of outstanding government loans and notes payable are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zL4tB0OrbXtf" style="display: none">Schedule of Future Maturities Outstanding of Government Loans and Notes Payable</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left">Twelve Months Ending February 28,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230228_zMHh28vmKax4"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDzvva_zQLN7UiAqn5l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">92,050</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_maLTDzvva_zp3ApAwIXYQ" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,768</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0_maLTDzvva_zAuyiOSxnQ01" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,768</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_maLTDzvva_zAGsxygxOQW5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,768</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_iI_pp0p0_maLTDzvva_zveAN2nM28Re" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,768</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_pp0p0_maLTDzvva_zEU8yMZnYsf7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,905</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDzvva_zdSwhn4hhVVh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">157,027</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zslho72lZir5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q1	us-gaap	Notes And Loans Payable NotesAndLoansPayable	157027	usd
CY2022Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	161460	usd
CY2023Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	92050	usd
CY2023Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	64977	usd
CY2022Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	161460	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-12-31
	us-gaap	Debt Instrument Description DebtInstrumentDescription	If the loan amount is paid on or before December 31, 2023, 25% of the loan will be forgiven (“Early Payment Credit”). In the event that the Company does not repay 75% of such term debt on or before December 31, 2023, the Early Payment Credit will not apply
	NVOS	Debt Instrument Forgiveness Applicable Repayment Rate DebtInstrumentForgivenessApplicableRepaymentRate	0.25	pure
	NVOS	Debt Instrument Default Repayment Percentage DebtInstrumentDefaultRepaymentPercentage	0.75	pure
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	20000	cad
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	92050	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	157027	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	16666666	usd
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	8333333	usd
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.05	pure
CY2021Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-14
CY2021Q4	us-gaap	Share Price SharePrice	2.00
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5833334	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.00
CY2021Q4	NVOS	Shares Adjustment Description SharesAdjustmentDescription	The warrants expire on December 14, 2025. The Company first determined the value of the $16.66m+ convertible notes and the fair value of the detachable warrants issued in connection with this transaction. The estimated value of the warrants of $7,680,156 was determined using the Black-Scholes option pricing model with the following assumptions:
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7680156	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P4Y
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	16666666	usd
CY2021Q4	NVOS	Discount On Convertable Note And Additional Paid In Capital DiscountOnConvertableNoteAndAdditionalPaidInCapital	5257466	usd
CY2021Q4	NVOS	Original Issue Discount OriginalIssueDiscount	1666666	usd
CY2021Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	1140000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.15	pure
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2021Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-05-17
CY2021Q4	us-gaap	Share Price SharePrice	3.35
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	223880	shares
CY2021Q4	us-gaap	Share Price SharePrice	3.35
CY2021Q4	NVOS	Shares Adjustment Description SharesAdjustmentDescription	The warrants expire on November 17, 2024. The Company first determined the value of the $1.875m convertible notes and the fair value of the detachable warrants issued in connection with this transaction. The estimated value of the warrants of $351,240 and was determined using the Black-Scholes option pricing model with the following assumptions
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	351240	usd
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1875000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1579176	usd
CY2021Q4	NVOS	Discount On Convertable Note And Additional Paid In Capital DiscountOnConvertableNoteAndAdditionalPaidInCapital	295824	usd
CY2021Q4	NVOS	Discount On Convertable Note And Additional Paid In Capital DiscountOnConvertableNoteAndAdditionalPaidInCapital	295824	usd
CY2021Q4	NVOS	Original Issue Discount OriginalIssueDiscount	375000	usd
CY2021Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	90000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	86327	usd
CY2023Q1	NVOS	Original Issue Discount OriginalIssueDiscount	57300	usd
CY2023Q1	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	70465	usd
	NVOS	Amortization Of Debt Discount Premiums AmortizationOfDebtDiscountPremiums	4069	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	292986	usd
CY2020Q3	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	267768	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	911623	usd
CY2022Q3	us-gaap	Secured Debt SecuredDebt	946250	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M14D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2250442	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2673934	usd
CY2023Q1	NVOS	Operating Lease Assets OperatingLeaseAssets	2250442	usd
CY2022Q3	NVOS	Operating Lease Assets OperatingLeaseAssets	2673934	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	473628	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	582088	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1890624	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2185329	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2364252	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2767417	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	655578	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	545682	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	493993	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	509226	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	352549	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	417595	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2974623	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	610371	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2364252	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	473628	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1890624	usd
	us-gaap	Payments For Rent PaymentsForRent	419256	usd
	us-gaap	Payments For Rent PaymentsForRent	392160	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	405082	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	381533	usd
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	209457	usd
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	192347	usd
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17110	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	16178	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	16178	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	240	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	15938	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	15938	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139626576	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139626576	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31180603	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31180603	shares
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	4000000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	4000000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	0.50
	us-gaap	Payments For Fees PaymentsForFees	140000	usd
	NVOS	Percentage Of Issuance Of Offering PercentageOfIssuanceOfOffering	0.070	pure
	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentGranted	8000000	shares
CY2023Q1	NVOS	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Non Option2 ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingNonOption2	1137959	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1159348	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2164235	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.15
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M10D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	140577	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2164235	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.17
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y11M23D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2164235	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.17
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y11M23D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2164235	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2164235	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.37
CY2022Q1	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Option Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionWeightedAverageExercisePrice	1.41
	us-gaap	Share Based Compensation ShareBasedCompensation	121774	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	154135	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.81	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.81	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	8445264	shares
CY2022Q3	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	2.42
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	9000000	shares
	NVOS	Share Based Compensation Arrangements By Share Based Payment Award Non Option Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionGrantsInPeriodWeightedAverageExercisePrice	0.12
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	7143334	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	10301930	shares
CY2023Q1	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	0.94
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm3	P3Y9M14D
CY2023Q1	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingIntrinsicValue	178623	usd
CY2023Q1	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisableNumber	10301930	shares
CY2023Q1	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	0.94
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionExercisableWeightedAverageRemainingContractualTerm1	P3Y9M14D
CY2023Q1	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionExercisableIntrinsicValue1	178623	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2556509	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2869223	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5975789	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6031150	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	970903	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1216354	usd
	us-gaap	Gross Profit GrossProfit	2710436	usd
	us-gaap	Gross Profit GrossProfit	2482820	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1786810	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2120676	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4028770	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3484335	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	552631	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	773555	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1138797	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1467837	usd
CY2022Q1	NVOS	Capital Expenditures CapitalExpenditures	72139	usd
	NVOS	Capital Expenditures CapitalExpenditures	192536	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	123866	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1226182	usd
	us-gaap	Interest Expense InterestExpense	291109	usd
	us-gaap	Interest Expense InterestExpense	1294912	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-4868204	usd
	us-gaap	Profit Loss ProfitLoss	-8581898	usd
	us-gaap	Profit Loss ProfitLoss	-6684599	usd
CY2023Q1	us-gaap	Assets Assets	36489318	usd
CY2022Q3	us-gaap	Assets Assets	40872840	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	923556	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1017405	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17199620	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18840619	usd
CY2023Q1	us-gaap	Goodwill Goodwill	7539469	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd

Files In Submission

Name	View Source	Status
0001493152-23-019347-index-headers.html	Edgar Link	pending
0001493152-23-019347-index.html	Edgar Link	pending
0001493152-23-019347.txt	Edgar Link	pending
0001493152-23-019347-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvos-20230228.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
nvos-20230228_def.xml	Edgar Link	unprocessable
nvos-20230228_cal.xml	Edgar Link	unprocessable
nvos-20230228_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
nvos-20230228_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

2023 Q1 Form 10-Q Financial Statement

#000149315223019347 Filed on May 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS Novo Integrated Sciences, Inc. Stock $nvos

2023 Q1 Form 10-Q Financial Statement

#000149315223019347 Filed on May 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos